Wells Fargo’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$144K Buy
127,551
+20,254
+19% +$22.9K ﹤0.01% 4566
2025
Q1
$157K Buy
107,297
+2,704
+3% +$3.95K ﹤0.01% 4409
2024
Q4
$223K Buy
104,593
+23,779
+29% +$50.6K ﹤0.01% 4253
2024
Q3
$226K Buy
80,814
+12,956
+19% +$36.3K ﹤0.01% 4104
2024
Q2
$158K Buy
67,858
+12,654
+23% +$29.5K ﹤0.01% 4308
2024
Q1
$247K Buy
55,204
+1,034
+2% +$4.62K ﹤0.01% 3982
2023
Q4
$174K Sell
54,170
-114,796
-68% -$368K ﹤0.01% 4153
2023
Q3
$536K Buy
168,966
+3,189
+2% +$10.1K ﹤0.01% 3466
2023
Q2
$824K Buy
165,777
+33,750
+26% +$168K ﹤0.01% 3409
2023
Q1
$652K Buy
132,027
+126,707
+2,382% +$626K ﹤0.01% 3435
2022
Q4
$33.5K Sell
5,320
-1,875
-26% -$11.8K ﹤0.01% 4730
2022
Q3
$78K Buy
7,195
+202
+3% +$2.19K ﹤0.01% 4444
2022
Q2
$79K Sell
6,993
-6,221
-47% -$70.3K ﹤0.01% 4514
2022
Q1
$121K Sell
13,214
-25,677
-66% -$235K ﹤0.01% 4908
2021
Q4
$580K Buy
38,891
+18,456
+90% +$275K ﹤0.01% 4251
2021
Q3
$526K Buy
20,435
+9,645
+89% +$248K ﹤0.01% 4374
2021
Q2
$281K Buy
10,790
+5,468
+103% +$142K ﹤0.01% 4600
2021
Q1
$187K Sell
5,322
-29,659
-85% -$1.04M ﹤0.01% 4863
2020
Q4
$883K Buy
34,981
+5,854
+20% +$148K ﹤0.01% 4053
2020
Q3
$1.1M Buy
29,127
+8,695
+43% +$328K ﹤0.01% 3710
2020
Q2
$874K Sell
20,432
-8,265
-29% -$354K ﹤0.01% 3813
2020
Q1
$558K Sell
28,697
-1,251
-4% -$24.3K ﹤0.01% 3838
2019
Q4
$777K Buy
29,948
+2,729
+10% +$70.8K ﹤0.01% 3960
2019
Q3
$742K Buy
27,219
+2,323
+9% +$63.3K ﹤0.01% 3995
2019
Q2
$668K Sell
24,896
-14,625
-37% -$392K ﹤0.01% 4085
2019
Q1
$1.14M Buy
39,521
+4,644
+13% +$134K ﹤0.01% 3740
2018
Q4
$939K Buy
+34,877
New +$939K ﹤0.01% 3804